ACXP Stock Analysis: Buy, Sell, or Hold?
ACXP - Acurx Pharmaceuticals, Inc. Common Stock
$2.41
0.03 (1.26%)
▲
5d:
-10.07%
30d:
-12.68%
90d:
-51.99%
WAIT
LOW Confidence
Last Updated: February 2, 2026
Earnings: Mar 16, 2026
Get Alerted When ACXP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called ACXP this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ACXP is down 10.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ACXP is down 10.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ACXP is currently trading at $2.41, which is considered oversold relative to its 30-day fair value range of $2.51 to $2.90.
Technical Outlook: Technically, ACXP is in a downtrend. Immediate support is located at $2.33, while resistance sits at $2.89.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $61.70 (+2492.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ACXP is in a downtrend. Immediate support is located at $2.33, while resistance sits at $2.89.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $61.70 (+2492.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$2.51 -
$2.90
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 2492.4% below Wall St target ($61.70)
- WARNING: Recommendation downgraded due to -10.1% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$2.51 -
$2.90
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$2.33
Resistance Level
$2.89
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-0.64
Wall Street Target
$61.70
(+2492.4%)
Last updated: February 03, 2026 9:54 AM ET
Data refreshes hourly during market hours. Next update: 10:54 AM
Data refreshes hourly during market hours. Next update: 10:54 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ACXP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 58 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$112 | 57 HOLD |
|
RNA
Avidity Biosciences Inc |
STRONG BUY
15 analysts |
$75 | 61 BUY |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$71 | 60 HOLD |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$42 | 56 HOLD |
